The most commonly reported adverse events in Phase 2 and Phase 3 trials were gastrointestinal in nature, including nausea, diarrhea, vomiting, and constipation
4) Ask About Additional Tests If Levels Stay High Without Supplements Your clinician may recommend further evaluation, such as: A complete blood count (CBC) to assess red and white blood cells and platelets
Green R, Allen LH, Bjrke-Monsen AL, Brito A, Guant JL, Miller JW, et al
Tricare coverage typically includes several essential levels of care, each to meet the diverse needs of individuals in recovery
GLP-1 Agonists (Semaglutide, Tirzepatide) GLP-1 receptor agonists like semaglutide and tirzepatide produce fat loss primarily through appetite suppression and reduced caloric intake rather than direct fat cell targeting
so far i have not had any nausea